Skip to main content
Evaxion A/S logo

Evaxion A/S — Investor Relations & Filings

Ticker · EVAX ISIN · US29970R3030 US Professional, scientific and technical activities
Filings indexed 327 across all filing types
Latest filing 2026-05-12 Foreign Filer Report
Country US United States of America
Listing US EVAX

About Evaxion A/S

https://evaxion.ai/

Evaxion A/S is a clinical-stage TechBio company specializing in the development of immunotherapies using its proprietary, clinically validated AI-Immunology™ platform. The platform leverages artificial intelligence and machine learning to decode the human immune system, enabling the rapid discovery and design of novel vaccine targets. Evaxion focuses on creating personalized and precision vaccines for the treatment of cancer and infectious diseases. Its pipeline includes personalized cancer vaccines in clinical development, such as EVX-01 for melanoma, and a preclinical portfolio targeting infectious diseases. The company's technology aims to accelerate the development of tailored vaccine candidates to address critical diseases.

Recent filings

Filing Released Lang Actions
6-K - Evaxion A/S (0001828253) (Filer)
Foreign Filer Report
2026-05-12 English
6-K - Evaxion A/S (0001828253) (Filer)
Foreign Filer Report
2026-05-07 English
6-K - Evaxion A/S (0001828253) (Filer)
Foreign Filer Report
2026-05-04 English
6-K - Evaxion A/S (0001828253) (Filer)
Foreign Filer Report
2026-04-27 English
6-K - Evaxion A/S (0001828253) (Filer)
Foreign Filer Report
2026-04-22 English
6-K - Evaxion A/S (0001828253) (Filer)
Foreign Filer Report
2026-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.